Our Take
A peer-reviewed signal that yoga may support the gut-brain axis in early Alzheimer's, but the study lacks the control group and scale needed to prove yoga caused the changes rather than other factors.
Why it matters
Alzheimer's has no cure and prevention remains elusive. Non-pharmacological interventions that are accessible and low-cost matter to patients and caregivers looking for adjunctive tools, especially if the gut-brain connection holds up in larger trials.
Do this week
Clinical teams: discuss structured yoga as a low-risk supplement alongside standard care for mild cognitive impairment patients, pending larger controlled trials, so you can offer an option patients can sustain.
AIIMS Tracked Yoga and Cognition in Mild Alzheimer's Patients
Researchers at All India Institute of Medical Sciences (AIIMS) in Delhi published findings in the Journal of Alzheimer's Disease showing that 12 weeks of supervised daily yoga correlated with measurable cognitive and mood improvements in patients with mild Alzheimer's disease. The study was conducted by the Departments of Anatomy and Neurology and included both Alzheimer's patients and cognitively healthy controls.
Patients participated in 60-minute yoga sessions every day for 12 weeks. Before and after, researchers measured cognitive performance using the Montreal Cognitive Assessment (MoCA) and depressive symptoms using the Patient Health Questionnaire-9 (PHQ-9). They also sampled gut microbiota composition.
Results showed significant improvements in MoCA scores and marked declines in PHQ-9 depression scores. Gut microbiome analysis revealed shifts toward a healthier microbial profile: beneficial bacteria such as faecalibacterium prausnitzii, roseburia intestinalis, bifidobacterium, and akkermansia increased, while pro-inflammatory microbes including collinsella aerofaciens and klebsiella species declined. The microbial profiles of Alzheimer's patients moved closer to those of healthy participants after the intervention.
Dr Rima Dada, corresponding author and Professor in the Department of Anatomy at AIIMS, noted that "enrichment of beneficial bacteria and reduction of pro-inflammatory microbes after yoga point towards biological mechanisms that could contribute to improved brain health." Dr Manjari Tripathi, Head of Neurology at AIIMS Delhi, cautioned that "yoga cannot be considered a cure for Alzheimer's disease" but may serve as an adjunctive therapy in early stages.
The Gut-Brain Axis Offers a Mechanistic Path, But Evidence Remains Preliminary
The study rests on the gut-brain axis hypothesis: alterations in gut microbes influence brain health through neurological signaling and inflammatory pathways. The appearance of short-chain fatty acid-producing bacteria after yoga and the reduction of pro-inflammatory species suggest a plausible biological mechanism. That matters because it moves the claim beyond "patients felt better" to "here is how the body may have changed."
However, the authors themselves flagged critical gaps. The study had no control group undergoing a different intervention—patients either did yoga or served as healthy baseline controls. Sample size was small. There was no dietary monitoring or metabolomic analysis to rule out confounding factors. Without a control arm (say, stretching or standard care), it remains unclear whether the cognitive gains came from yoga specifically, from daily supervised activity, from stress reduction, or from regression to the mean.
Larger randomized controlled trials with longer follow-up and integration of immune markers would be needed to confirm whether yoga directly causes the observed changes. Until then, the finding is a promising signal in a population with few non-pharmacological options, not a validated intervention.
Offer Yoga as a Complement, Not a Substitute, and Set Clear Expectations
For clinicians and care teams working with mild Alzheimer's and mild cognitive impairment patients, this study provides preliminary justification to discuss structured yoga as a low-risk, accessible adjunct to pharmacotherapy and cognitive training. The cost is minimal and the time burden—daily 60-minute sessions—is feasible for motivated patients and caregivers.
The critical conversation is framing. Do not present yoga as a disease modifier or memory cure. Present it as a non-pharmacological tool that *may* support mood and cognition while we await larger trials. Pair it with realistic expectations: improvement in this study was associated with, not proven caused by, yoga. Monitor mood and cognitive function over time using the same instruments (MoCA, PHQ-9) so you can measure whether a given patient benefits. If the field produces a well-controlled trial in the next 18 months, adjust your counsel accordingly.